Structure and dimerization of a soluble form of B7-1

Immunity

Volumn 12, Issue 1, 2000, Pages 51-60

  Ikemizu, Shinji ^a   Gilbert, Robert J C ^a,c   Fennelly, Janet A ^b   Collins, Alison V ^b   Harlos, Karl ^a,c   Jones, E Yvonne ^a,c   Stuart, David I ^a,c   Davis, Simon J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CELL ADHESION MOLECULE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; DIMERIZATION; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; T LYMPHOCYTE;

EID: 0033971597     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80158-2     Document Type: Article

References (80)

1. Aruffo, A., and Seed, B. (1987). Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84, 8573-8577.
2. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L., and Somoza, C. (1993). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
3. Bajorath, J., Peach, R.J., and Linsley, P.S. (1994). Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci. 3, 2148-2150.
4. Barclay, A.N., Brown, M.H., Law, S.K.A., McKnight, A.J., Tomlinson, M.G., and van der Merwe, P.A. (1997). The Leukocyte Antigen Factsbook (London: Academic Press).
5. Bodian, D.L., Jones, E.Y., Harlos, K., Stuart, D.I., and Davis, S.J. (1994). Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 15, 755-766.
6. Borriello, F., Sethna, M.P., Boyd, S.D., Schweitzer, A.N., Tivol, E.A., Jacoby, D., Strom, T.B., Simpson, E.M., Freeman, G.J., and Sharpe, A.M. (1997). B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313.
7. Brunet, J.F., Denizot, F., Luciani, M.F., Roux-Dosseto, M., Suzan, M., Mattei, M.G., and Golstein, P. (1987). A new member of the immunoglobulin superfamily - CTLA-4. Nature 328, 267-270.
8. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. (1998). Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921.
9. Butters, T.D., Sparks, L.M., Harlos, K., Ikemizu, S., Stuart, D.I., Jones, E.Y., and Davis, S.J. (1999). Additive effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in chinese hamster ovary cells: application to glycoprotein crystallisation. Proteins 8, 1707-1712.
10. Cann, J.R. (1986). Effects of microheterogeneity on sedimentation patterns of interacting proteins and the sedimentation behavior of systems involving two ligands. Methods Enzymol. 130, 19-35.
11. CCP4 (1994). Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
12. Chen, L., Ashe, S., Brady, W.A., Hellstrom, I., Hellstrom, K.E., Ledbetter, J.A., McGowan, P., and Linsley P.S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
13. Davis, S.J., and van der Merwe, P.A. (1996). The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17, 177-187.
14. Davis, S.J., Davies, E.A., Tucknott, M.G., Jones, E.Y., and van der Merwe, P.A. (1998a). The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. Proc. Natl. Acad. Sci. USA 95, 5490-5494.
15. Davis, S.J., Ikemizu, S., Wild, M.K., and van der Merwe, P.A. (1998b). CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol. Rev. 163, 217-236.
16. Dayhoff, M.O., Barker, W.C., and Hunt, L.T. (1983). Establishing homologies in protein sequences. Methods Enzymol. 91, 524-545.
17. Dustin, M.L., Ferguson, L.M., Chan, P.Y., Springer, T.A, and Golan, D.E. (1996). Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J. Cell. Biol. 132, 465-474.
18. Dustin, M.L., Golan, D.E., Zhu, D.M., Miller, J.M., Meier, W., Davies, E.A., and van der Merwe, P.A. (1997). Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 272, 30889-30898.
19. Dustin, M.L., Olszowy, M.W., Holdorf, A.D., Li, J., Bromley, S., Desai, N., Widder, P., Rosenberger, F., van der Merwe, P.A., Allen, P.M., and Shaw, A.S. (1998). A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94, 667-677.
20. Esnouf, R.M. (1997). An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15, 132-134, 112-113.
21. Finck, B.K., Linsley, P.S., and Wofsy, D. (1994). Treatment of murine lupus with CTLA4Ig. Science 265, 1225-1227.
22. Freeman, G.J., Freedman, A.S., Segil, J.M., Lee, G., Whitman, J.F., and Nadler, L.M. (1989). B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714-2722.
23. Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo, V.A., Jr., Lombard, L.A., Gray, G.S., and Nadler, L.M. (1993a). Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909-911.
24. Freeman, G.J., Borriello, F., Hodes, R.J., Reiser, H., Hathcock, K.S., Laszlo, G., McKnight, A.J., Kim, J., Du, L., Lombard, D.B., et al. (1993b). Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907-909.
25. Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.Y., Rennert, P.D., Gray, G.S., Gribben, J.G., and Nadler, L.M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
26. Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M., and Dustin, M.L. (1999). The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221-227.
27. Greenfield, E.A., Nguyen, K.A., and Kuchroo, V.K. (1998). CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18, 389-418.
28. Guinan, E.C., Boussiotis, V.A., Neuberg, D., Brennan, L.L., Hirano, N., Nadler, L.M., and Gribben, J.G. (1999). Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340, 1704-1714.
29. Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H., and Allison, J.P. (1992). CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
30. Henry, J., Ribouchon, M., Depetris, D., Mattei, M., Offer, C., Tazi-Ahnini, R., and Pontarotti, P. (1997). Cloning, structural analysis, and mapping of the B30 and B7 multigenic families to the major histocompatibility complex (MHC) and other chromosomal regions. Immunogenetics 46, 383-395.
31. Holm, L., and Sander, C. (1995). Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20, 478-480.
32. Hutloff, A., Dittrich, A.M., Beier, K.C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., and Kroczek, R.A. (1999). ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266.
33. Janin, J., and Chothia, C. (1990). The structure of protein-protein recognition sites. J. Biol. Chem. 265, 16027-16030.
34. Jones, E.Y., Davis, S.J., Williams, A.F., Harlos, K., and Stuart, D.I. (1992). Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2. Nature 360, 232-239.
35. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991). Improved methods for finding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
36. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N., and Glimcher, L.H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/ Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
37. Larsen, C.P., Elwood, E.T., Alexander, D.Z., Ritchie, S.C., Hendrix, R., Tucker-Burden, C., Cho, H.R., Aruffo, A., Hollenbaugh, D., Linsley, P.S., et al. (1996). Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
38. Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
39. Laue, T.M. (1992). Technical Information DS-835 (Palo Alto, CA: Spinco Business Unit).
40. Leach, D.R., Krummel, M.F., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736.
41. Lee, K.M., Chuang, E., Griffin, M., Khattri, R., Hong, D.K., Zhang, W., Straus, D., Samelson, L.E., Thompson, C.B., and Bluestone, J.A. (1999). Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263-2266.
42. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. (1996). CD28/ B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
43. Leung, H.T., Bradshaw, J., Cleaveland, J.S., and Linsley, P.S. (1995). Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270, 25107-25114.
44. Linsley, P.S., Greene, J.L., Tan, P., Bradshaw, J., Ledbetter, J.A., Anasetti, C., and Damle, N.K. (1992a). Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595-1604.
45. Linsley, P.S., Wallace, P.M., Johnson, J., Gibson, M.G., Greene, J.L., Ledbetter, J.A., Singh, C., and Tepper, M.A. (1992b). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795.
46. Linsley, P.S., Peach, R., Gladstone, P., and Bajorath, J. (1994). Extending the B7 (CD80) gene family. Protein Sci. 3, 1341-1343.
47. Linsley, P.S., Bradshaw, J., Greene, J., Peach, R., Bennett, K.L., and Mittler, R.S. (1996). Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4, 535-543.
48. Mandelbrot, D.A., McAdam, A.J., and Sharpe, A.H. (1999). B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189, 435-440.
49. Marengere, L.E., Waterhouse, P., Duncan, G.S., Mittrucker, H.W., Feng, G.S., and Mak, T.W. (1996). Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170-1173.
50. Martin, P.J., Ledbetter, J.A., Morishita, Y., June, C.H., Beatty, P.G., and Hansen, J.A. (1986). A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J. Immunol. 136, 3282-3287.
51. May, A.P., Robinson, R.C., Aplin, R.T., Bradfield, P., Crocker, P.R., and Jones, E.Y. (1997). Expression, crystallization, and preliminary X-ray analysis of a sialicacid-binding fragment of sialoadhesin in the presence and absence of ligand. Protein Sci. 6, 717-721.
52. McAdam, A.J., Schweitzer, A.N., and Sharpe, A.H. (1998). The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol. Rev. 165, 231-247.
53. Merritt, E.A., and Murphy, M.E.P. (1994). Raster3D version 2.0: a program for photorealistic molecular graphics. Acta Cryst. D 50, 869-873.
54. Metzler, W.J., Bajorath, J., Fenderson, W., Shaw, S.Y., Constantine, K.L., Naemura, J., Leytze, G., Peach, R.J., Lavoie, T.B., Mueller, L., and Linsley, P.S. (1997). Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat. Struct. Biol. 4, 527-531.
55. Monks, C.R., Freiberg, B.A., Kupfer, H., Sciaky, N., and Kupfer, A. (1998). Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86.
56. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
57. Olsson, C., Riebeck, K., Dohlsten, M., and Michaelsson, E. (1999). CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts. J. Biol. Chem. 274, 14400-14405.
58. O'Regan, M.N., Parsons, K.R., Tregaskes, C.A., and Young, J.R. (1999). A chicken homologue of the co-stimulating molecule CD80 which binds to mammalian CTLA-4. Immunogenetics 1, 68-71.
59. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
60. Peach, R.J., Bajorath, J., Naemura, J., Leytze, G., Greene, J., Aruffo, A., and Linsley, P.S. (1995). Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 8, 21181-21187.
61. Perkins, S.J. (1986). Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering match-points and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences. Eur. J. Biochem. 157,169-180.
62. Schweitzer, A.N., Borriello, F., Wong, R.C., Abbas, A.K., and Sharpe, A.H. (1997). Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158, 2713-2722.
63. Shapiro, L., Doyle, J.P., Hensley, P., Colman, D.R., and Hendrickson, W.A. (1996). Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 77, 435-449.
64. Slavik, J.M., Hutchcroft, J.E., and Bierer, B.E. (1999). CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J. Biol. Chem. 274, 3116-3124.
65. Springer, T.A. (1991). Cell adhesion. A birth certificate for CD2. Nature 353, 704-705.
66. Stafford, W.F., III (1992). Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal. Biochem. 203, 295-301.
67. Stuart, D.I., Levine, M., Muirhead, H., and Stammers, D.K. (1979). Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å. J. Mol. Biol. 134, 109-142.
68. Terwilliger, T.C., and Berendzen, J. (1997). Bayesian MAD phasing. Acta Cryst. D 53, 571-579.
69. Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680.
70. Townsend, S.E., and Allison, J.P. (1993). Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259, 368-370.
71. Tuma, R., Bamford, J.H., Bamford, D.H., Russell, M.P., and Thomas, G.J., Jr. (1996). Structure, interactions and dynamics of PRD1 virus I. Coupling of subunit folding and capsid assembly. J. Mol. Biol. 257, 87-101.
72. van der Merwe, P.A., McNamee, P.N., Davies, E.A., Barclay, A.N., and Davis, S.J. (1995). Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr. Biol. 5, 74-84.
73. van der Merwe, P.A., Bodian, D.L., Daenke, S., Linsley, P., and Davis, S.J. (1997). CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185, 393-403.
74. Viola, A., Schroeder, S., Sakakibara, Y., and Lanzavecchia, A. (1999). T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680-682.
75. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
76. Wang, J.H., Smolyar, A., Tan, K., Liu, J.H., Kim, M., Sun, Z.Y., Wagner, G., and Reinherz, E.L. (1999). Structure of a heterophilic adhesion complex between the human CD2 and CD58(LFA-3) counterreceptors. Cell 97, 791-803.
77. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
78. Weiss, A., Manger, B., and Imboden, J. (1986). Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J. Immunol. 137, 819-825.
79. Williams, A.F., and Barclay, A.N. (1988). The immunoglobulin superfamily - domains for cell surface recognition. Annu. Rev. Immunol. 6, 381-405.
80. Wülfing, C., and Davis, M.M. (1999). A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282, 2266-2269.